Table 2.
Total | Male | Female | ||||
---|---|---|---|---|---|---|
OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
Ref:Meeting 0 | ||||||
Meeting 1 | 1.09 (0.84~1.42) | 0.487 | 0.94 (0.67~1.34) | 0.770 | 1.32 (0.87~2.01) | 0.185 |
Meeting 2 | 1.44 (1.06~1.89) | 0.007 | 1.32 (0.92~1.88) | 0.122 | 1.63 (1.07~2.49) | 0.022 |
Meeting 3 | 1.81 (0.93~3.50) | 0.049 | 0.87 (0.32~2.31) | 0.786 | 3.30 (1.25~8.69) | 0.016 |
Ref:Meeting 1 | ||||||
Meeting 2 | 1.31 (1.11~1.55) | 0.001 | 1.39 (1.12~1.74) | 0.004 | 1.23 (0.49~1.14) | 0.089 |
Meeting 3 | 1.64 (0.88~3.08) | 0.118 | 0.91 (0.36~2.34) | 0.861 | 2.48 (1.01~6.16) | 0.049 |
Ref:Meeting 2 | ||||||
Meeting 3 | 1.24(0.66~2.33) | 0.486 | 0.66(0.25~1.68) | 0.387 | 2.01 (0.81~4.99) | 0.130 |
Ref: reference group; p-values in bold indicate significant levels < 0.05.